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Radiotherapy of locally advanced laryngeal cancer:
the Gliwice Center of Oncology experience, 1990-1996
Anna Mucha-Ma∏ecka, Krzysztof Sk∏adowski, Andrzej Wygoda,
Wojciech Sàsiadek, Rafa∏ Tarnawski
I n t r o d u c t i o n s.  The aim of the study was to assess the efficacy of radiotherapy alone in patients with locally advanced la-
ryngeal cancer T3-T4, and to establish the prognostic value of the size and the location of the extralaryngeal infiltrations and
of emergency tracheostomy.
M a t e r i a l  a n d  m e t h o d s .  296 patients with advanced squamous cell cancer of the larynx were radically tre-
ated with radiotherapy alone in Center of Oncology in Gliwice between the years 1990 and 1996. There were 221 cases of
supraglottic cancer (75%) and 75 of glottic cancer (25%). The stages were as follows: supraglottic cancer: T3 – 113
(51%), T4 – 108 (49%), glottic cancer: T3 – 69 (92%), T4 – 6 (8%). Positive neck nodes were found in 100 patients with
supraglottic cancer (45%), and only in 11 patients with glottic cancer (15%). In cases of extralaryngeal invasion (T4) the
pyriform recess was involved in 33%, the base of tongue and valleculae glosso-epiglotticae in 30%, the hypopharyngeal wall
in 9% of cases, while a massive involvement of the larynx, the pyriform recess and the base of the tongue was found in 6%
of patients. Cartilage involvement was suspected in 22% of patients. Thirty six patients (12%) underwent emergency tra-
cheostomy.
R e s u l t s.  Generally, the 3-year local control rate (LC) and disease free survival rate (DSF) were 46% and 41%, respec-
tively. The probability of LC was similar in both supraglottic and glottic cancer: 44% and 47.5% respectively. The presen-
ce of involved neck nodes significantly decreased LC and DFS rates in both groups (about 20%). For stage T4 laryngeal
cancer the LC rate was correlated with the location of the extralaryngeal infiltrations. Best prognosis was connected with
the suspicion of cartilage infiltration – 56% of 3-year LC rate. The worst results were noted in cases of massive infiltrations
spreading from larynx through the hypopharynx – 13.5% of 3-year LC rate. Emergency tracheostomy before radiotherapy
was very significantly linked to poorer treatment results. The 3-year LC rate in tracheostomy patients was 6%, as compa-
ried to 51% in other patients. Multivariate analysis using Cox regression model showed that the worst prognosis was signi-
ficantly and independently connected with the necessity of emergency tracheostomy before treatment, and neck lymph no-
de involvement.
C o n c l u s i o n s.  Conventional radiotherapy of advanced laryngeal cancer has limited effiacy as a method of radical treat-
ment. Emergency tracheostomy and the involvement of neck lymph nodes are poor prognostic factors in the case of patients
with advanced laryngeal cancer treated with radiotherapy alone. The efficacy of radiotherapy in stage T4 laryngeal cancer is
directly connected with the localisation and the extent of extralaryngeal infiltrations.
Radioterapia chorych na miejscowo zaawansowanego raka krtani
w materiale klinicznym Centrum Onkologii w Gliwicach w latach 1990-96
W s t ´ p.  Celem pracy jest ocena skutecznoÊci samodzielnego, radykalnego, leczenia promieniami chorych na miejscowo
zaawansowanego raka krtani (T3-T4), w latach 1990-96 w Centrum Onkologii w Gliwicach oraz ustalenie rokowniczego
znaczenia wielkoÊci i umiejscowienia nowotworowych nacieków pozakrtaniowych oraz tracheostomii, wykonanej przed le-
czeniem.
M a t e r i a ∏  i m e t o d y.  Materia∏ kliniczny stanowi 296 przypadków zaawansowanego p∏askonab∏onkowego raka krtani, le-
czonych radykalnie samodzielnym napromienianiem. Przedmiotem analizy jest grupa 221 przypadków raka nadg∏oÊni
(75%) i 75 przypadków raka g∏oÊni (25%). W grupie chorych na raka nadg∏oÊni zanotowano nast´pujàce stopnie zaawanso-
wania guza pierwotnego: T3 – 113 przypadków (51%) i T4 – 108 (49%), a w grupie chorych na raka g∏oÊni: T3 – 69 (92%)
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Introduction
Laryngeal cancer is the most common cancer of the
head and neck region, accounting for approximately
6% of all malignancies. The methods of treatment are
either surgery or radiotherapy alone or surgery fol-
lowed by postoperative radiotherapy. Radiotherapy alo-
ne is a recognized method of treatment for stage I and II
laryngeal cancer, allowing to achieve results comparable
to surgery and, at the same time, ensure voice prese-
rvation [1, 2]. In such patients surgery is used only as
a „salvage” procedure for the recurrences after radiothe-
rapy. Surgery is recommended for stages III and IV la-
ryngeal cancer. In cases with significant risk of recur-
rence surgery is combined with radiotherapy [3-6]. In
these patients radiotherapy alone is applied only when
the patient does not consent or is unsuitable for surgery.
Patients not suitable for surgery due to the advanced
stage of the disease are irradiated palliatively. In some of
these cases attempts of radical radiotherapy are also
made.
Results of treatment with radiotherapy alone in ad-
vanced laryngeal cancer are generally worse than the re-
sults achieved with surgery followed by radiotherapy.
However, as a group these patients are clinically hetero-
genous in term of radiocurability – a review of literature
shows a wide range of cures, ranging from 10% to even
80% [2, 3, 7]. Such results suggest the possibility of the
influence of many prognostic factors. Apart from those
well known, such as clinical stage and type of infiltra-
tion (egzophytic, endophytic), a very important progno-
stic factor is also the primary location of the cancer wi-
thin the larynx. Supraglottic carcinomas usually do not
keratinize or are poorly differentiated (G2 – 3), and ge-
nerally grow more aggressively than glottic carcinomas
[8, 9].
Glottic carcinomas usually keratinize, are well dif-
ferentiated (G1), and grow less aggressively [10, 11].
The purpose of this study is to assess the efficacy of ra-
diotherapy alone in patients with locally advanced la-
ryngeal cancer T3 – T4 treated between the years 1990
and 1996 at the Centre of Oncology in Gliwice, and to
establish the prognostic value of the size and location of
extralaryngeal infiltrations and of emergency trache-
ostomy.
Material and methods
Two hundred ninety six patients with advanced squamous
cell cancer of the larynx were radically treated with radiotherapy
alone at the Centre of Oncology in Gliwice between the years
1990 and 1996 (31% of all laryngeal cancers irradiated in this
period of time); the characteristics of patients is presented in Ta-
ble I. Two groups: 221 patients with supraglottic cancer (75%)
and 75 patients with glottic cancer (25%) were analysed. No ca-
ses of infraglottic cancer were observed during this time.
In 36/296 cases (12%) emergency tracheostomy was perfor-
med before the onset of tretment because of dyspnea of these, 27
cases were supraglottic and 9 glottic.
In a majority of cases (70%), the performance status at
the onset of treatment was assessed as very good (ZUBROD 0).
The performance status of the remaining patients was pronoun-
ced as good (ZUBROD 1 – 28%) or medium (ZUBROD 2).
Clinical staging was established according to TNM UICC
from 1984. Tables II and III show the size of primary tumor (T)
i T4 – 6 (8%). U 100 chorych (45%) na raka nadg∏oÊni stwierdzono obecnoÊç przerzutów do regionalnych w´z∏ów ch∏onnych
szyi, natomiast przerzutowo zaj´te w´z∏y ch∏onne w przypadku raka g∏oÊni zanotowano u 11 chorych (15%). W przypadkach
naciekania raka poza krtaƒ (T4) najcz´Êciej by∏ zaj´ty zachy∏ek gruszkowaty – 37 chorych (33%), prawie równie cz´sto do∏ek
j´zykowo-nag∏oÊniowy i nasada j´zyka – 34 chorych (30%); nacieki Êcian gard∏a dolnego zanotowano u 10 chorych (9%), roz-
leg∏e nacieki, szerzàce si´ od zachy∏ka gruszkowatego do nasady j´zyka, zanotowano u 7 chorych (6%). U 26 chorych
(22%) podejrzewano naciekanie zr´bu chrz´stnego krtani. W 36 przypadkach (12%) z powodu dusznoÊci wykonano trache-
ostomi´ przed rozpocz´ciem leczenia.
W y n i k i.  Ogó∏em w 3-letnim okresie obserwacji wyleczenie miejscowe zanotowano w 46% przypadków, a prze˝ycie bezob-
jawowe w 41%. Odsetek miejscowego wyleczenia raka krtani dla obydwu lokalizacji by∏ podobny i wynosi∏: 44% dla pi´tra gór-
nego i 47,5% dla pi´tra Êrodkowego krtani. Przerzutowo zaj´te w´z∏y ch∏onne szyi w sposób statystycznie znamienny obni˝a-
jà odsetek wyleczeƒ miejscowych i prze˝yç bezobjawowych w obydwóch stopniach zaawansowania o oko∏o 20%. W przypad-
ku raka krtani o zaawansowaniu T4 wyleczenie miejscowe zale˝a∏o od lokalizacji i wielkoÊci nacieku pozakrtaniowego.
Najlepsze rokowanie by∏o zwiàzane z podejrzeniem naciekania zr´bu chrz´stnego krtani i wynosi∏o 56% 3 letnich wyleczeƒ
miejscowych, najgorsze wyniki leczenia zanotowano w przypadku rozleg∏ych nacieków, szerzàcych si´ z krtani poprzez gard∏o
dolne do gard∏a Êrodkowego, 13,5% 3-letnich wyleczeƒ miejscowych. KoniecznoÊç wykonania tracheostomii przed radiotera-
pià by∏a znamiennie zwiàzana z najgorszymi wynikami leczenia, 3-letnie wyleczenie miejscowe u chorych z tracheostomià wy-
nosi∏o 6% w porównaniu do 51% u chorych bez tracheostomii. Analiza wieloczynnikowa wykaza∏a, ˝e na z∏e rokowanie w wy-
soce znamienny i niezale˝ny sposób wp∏ywa tracheostomia wykonana przed leczeniem oraz obecnoÊç przerzutów w regional-
nych w´z∏ach ch∏onnych.
W n i o s k i.  Konwencjonalna radioterapia chorych na zaawansowanego raka krtani jest metodà leczenia o ograniczonej sku-
tecznoÊci. Na wyniki leczenia w sposób statystycznie znamienny wp∏ywa obecnoÊç przerzutów w regionalnych w´z∏ach ch∏on-
nych oraz tracheostomia wykonana przed leczeniem. SkutecznoÊç leczenia raka krtani o zaawansowaniu T4 jest ÊciÊle zwià-
zana z lokalizacjà i wielkoÊcià nacieków pozakrtaniowych.
Key words: advanced laryngeal cancer, radiotherapy
S∏owa kluczowe: zaawansowany rak krtani, radioterapia
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and neck node involvement (N) in patients with supraglottic
and glottic cancer, respectively. There were 160 (54%) stage III
and 136 (46%) stage IV cases.
The size of the primary tumor was as follows: supraglottic
cancer T3 – 113 (51%), T4 – 108 (49%), glottic cancer T3 – 69
(92%), T4 – 6 (8%). Positive neck nodes were found in 100 pa-
tients with supraglottic cancer (45%), and only in 11 patients
with glottic cancer (15%). In a majority of cases they were staged
as N1 and N2 (21% and 22% for supraglottic cancer and 9% and
4% for glottic cancer respectively) (Table II and III).
In cases of extralaryngeal infiltration (T4) the piriform re-
cess was involved – in 37 cases (33%), the base of tongue and
valleculae glosso-epiglotticae in 34 cases (30%), and the hypo-
pharyngeal wall in 10 (9%). Massive involvement of the piri-
form recess, the valleculae glosso-epiglotticae and the base of the
tongue was found in 7 cases (6%). Cartilage involvement was su-
spected on clinical examination in 26 cases (22%).
All patients were irradiated using a Cobalt 60 unit with
two contralateral fields including the primary tumor and
the involved neck nodes. The total dose depended on the si-
ze of the primary tumor ranging from 60 Gy to 78 Gy (mean
66.8 Gy) and was conventionally fractionated. Metastatic
neck nodes situated inside the fields including the primary
tumor were irradiated with a fraction dose, which on the level
of the node, was comparable to the fraction dose in the re-
gion of the primary tumor (the difference not exceeding 5%).
The remaining neck nodes (outside the fields including prima-
ry tumor) were irradiated with an additional field matched indi-
vidually. In cases of persistent, enlarged neck nodes (N2-3)
a boost dose of about 10 Gy was given using the shrinked field
technique. Clinically uninvolved neck nodes were electively ir-
radiated to a total dose of 50 Gy given at a depth of 2.5 cm. The
total treatment time ranged widely from 39 to 103 days (mean:
49 days).
Three criteria evaluating the efficacy of treatment were: 3-
-year local control (LC), disease free survival (DFS) and overall
survival (OS). All these parameters were estimated with the
Kaplan-Meier method. The differences in survival dependant
Tab. I. The characteristics of patients
Category Number of patients (%)
Supraglottis Glottis
Sex M 197 (89%) 73 (97%)
F 24 (11%) 2 (3%)
Age median 57 years 59 years
minimum 33 35
maximum 86 80
Extent of primary tumor T3 113 (51%) 69 (92%)
T4 108 (49%) 6 (8%)
Neck lymph nodes N0 121 (54%) 64 (85.5%)
N1 44 (21%) 7 (9%)
N2 48 (22%) 3 (4%)
N3 8 (3%) 1 (1.5%)
N+ 100 (46%) 11 (14.5%)
Tracheostomy yes 27 (12%) 9 (12%)
no 194 (88%) 66 (88%)
Performance status (ZUBROD) 0 153 (69%) 54 (72%)
1 63 (29%) 20 (27%)
2 5 (2%) 1 (1%)
Tab. II. The extent of primary supraglottic tumor (T) and neck lymph nodes involvement (N)
Extent of primary Neck nodes involvement
tumor (number of patients)
N0 N1 N2 N3 TOTAL
T3 70 (31.0%) 23 (11.0%) 17 (8.0%) 3 (1.0%) 113 (51.0%)
T4 51 (23.0%) 21 (10.0%) 31 (14.0%) 5 (2.0%) 108 (49.0%)
TOTAL 121 (54.0%) 44 (21.0%) 48 (22.0%) 8 (3.0%) 221 (100%)
Tab. III. The  extent of primary glottic tumor (T) and neck lymph nodes involvement (N)
Extent of primary Neck nodes involvement
tumor (number of patients)
N0 N1 N2 N3 TOTAL
T3 60 (80.0%) 7 (9.0%) 1 (1.5%) 1 (1.5%) 69 (92.0%)
T4 4 (5.5%) - 2 (2.5%) - 6 (8.0%)
TOTAL 64 (85.5%) 7 (9.0%) 3 (4.0%) 1 (1.5%) 75 (100%)
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on the selected clinical and therapeutic factors were compared
with the log-rank test; p value below 0.05 was taken to be statisti-
cally significant. Multivariate analysis of the prognostic factors
using Cox regression model was also performed.
Results
The 3-year local control (LC) was noted in 46% of cases
(Fig.1), disease free survival (DFS) in 41% (Fig.1) and
overall survival (OS) in 48%. In the group of patients
with supraglottic cancer the 3-year DFS was 40% and
LC was 44%, as compared to patients with glottic cancer:
44% and 47.5%, respectively. The 3-year DFS was similar
in male and female patients with supraglottic cancer –
40% and 44%, respectively. Due to a limited number of
women with glottic cancer reliable analysis was impossible
in this group (Tab. IV).
The LC rates in patients with stage T3 were similar
in both supraglottic and glottic cancer groups and equal-
led 47%. The group of patients with T4 glottic cancer
was too small to perform a similar analysis (6 patients).
The presence of involved neck nodes significantly worse-
ned the LC and DFS rates. The 3-year LC rate in stage
T3 without neck node involvement (N0) was 54%, as
compared to 30% in the N+ group (p=0.008) (Fig.2).
In the group of patients with stage T4 similar results we-
re observed – 50% and 33% respectively (p=0.060)
(Fig. 3).
For stage T4 laryngeal cancer the LC rate was corre-
lated with the location of the extralaryngeal infiltration.
Best prognosis was connected with the suspicion of carti-
Tab. IV. The relationship between selected clinical factors and 3-year DFS (disease free survival) and LC (local control) rates
in patients with supraglottic and glottic cancer
Clinical Supraglottic cancer Glottic cancer
factor Category (p)* (p)
3-year DFS 3-year LC 3-year DFS 3-year LC
Sex M 40.0 NS 43.0 NS 43.0 46.0
F 44.0 47.0 - -
Extent of primary tumor T3 45.0 NS 47.0 NS 44.0 NS 47.0 NS
T4 35.0 40.5 50.0 50.0
T3-T4 40.0 44.0 45.0 47.5
Extent of neck nodes N0 50.0 p =0.001 53.0 p=0.001 50.0 p=0.060 53.0 p=0.060
involvement N1 38.0 41.0 13.0 14.0
N2 23.0 31.0 33.0 33.0
N3 - - - -
N+ 28.0 33.0 17.0 18.0
Tracheostomy Yes 4.0 p=0.000 3.0 p=0.000 11.0 p=0.020 11.0 p=0.005
No 47.0 51.0 49.0 53.0
*(p) – probability of difference
Fig. 1. Local control and disease free survival curves for patients with
T3 – T4  laryngeal cancer.
Fig. 2. Local control curves for patients with T3 laryngeal cancer accor-
ding to the  extent of neck nodes involvement
Fig. 3. Local control curves for patients with T4 laryngeal cancer accor-
ding to the extent of neck nodes involvement
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lage infiltration – 56% of 3-year LC rate (Fig. 4). The
worst results were noted in cases of massive infiltrations
spreading from larynx through the hypopharynx – 13.5%
of 3-year LC rate (p=0.034).
Emergency tracheostomy before radiotherapy was
very significantly (p=0.000) connected with worse treat-
ment results. The 3-year LC rate in tracheostomy pa-
tients was 6%, as compared to 51% in non-tracheostomy
patients (Fig. 5).
Multivariate analysis using the Cox regression model
allowed to separate independent prognostic factors in-
fluencing the efficacy of radiotherapy of the advanced
laryngeal cancer (Tab. V). The DFS of patients with ad-
vanced laryngeal cancer was very significantly and inde-
pendently influenced by the necessity of emergency tra-
cheostomy before treatment and the presence of neck
node involvement.
Distant metastases were observed in 16 cases (5%)
(13 cases of supraglottic cancer and 3 cases of glottic can-
cer). In a majority of cases they were located in the lungs
(13 cases). There were also a few cases of metastases to
the bones, the brain and the mediastinal nodes.
Salvage treatment was performed only in 17 patients
(12%) in whom treatment failure after radiotherapy was
recognized.
Discussion
Our study of a group of 296 patients shows, that conven-
tional radiotherapy is of limited effectiveness in the treat-
ment of advanced supraglottic and glottic cancer (T3-4
N0-3). The basic cause of failure is the lack of cure of
either the primary tumor and/or large neck nodes meta-
stases. Some authors suggest that higher total doses of
radiation may lead not only to increased tumor cure but
also to an increased risk of radiation-induced complica-
tions [8, 12, 13]. Our results resemble those found in lite-
rature and suggest that patients with advanced laryngeal
cancer should be primarily treated surgically with possible
adjuvant radiotherapy [3, 14, 15]. In our group, radiothe-
rapy alone allows to achieve a 3-year LC rate of 40-47%,
depending to the location of the primary tumor. Our re-
sults are consistent with the observations of Sko∏yszewski
et al. [3].
Mendenhall et al., in a comparable clinical material,
have achieved better treatment results. In case of irradia-
tion with two daily fractions (hyperfractionation) 5-year
LC after radiotherapy alone was approximately 65%, and
after „salvage” surgery it reached even 90%. With co-
nventional radiotherapy these results were 53% and 71%,
respectively [7]. Similar results were reported by Wang.
The 5-year LC equalled 67% after hyperfractionated ra-
diotherapy, as compared to 42% after conventional treat-
ment [16].
Our study shows that the extent of neck node invo-
lvement (N+) significantly worsens the prognosis for both
Fig. 5. Local control curves for patients with T3-T4 laryngeal cancer
with or without emergency tracheostomy
Fig. 4. Local control curves for patients with T4 laryngeal cancer accor-
ding to the directions of extralaryngeal tumor infiltration
Tab. V. The relationship between selected prognostic factors and DFS in patients with T3-4 laryngeal cancer after radiotherapy (final model:
x2=26,52; df=3, p=0.000)
Factor Category Standard error Relative risk 95% CI
β β (RR) of RR p
Tracheostomy No - 1.00 -
Yes 0.742 0.197 2.10 1.43-3.09 0.000
Enlarged neck nodes N0 - 1.00 - 0.000
N1 0.286 0.083 1.33 1.13-1.57
N2 0.572 0.083 1.77 1.50-2.08
N3 0.858 0.083 2.36 2.00-2.78
Age continuous 0.013 0.008 1% 1.00-1.03 0.115
from 33 for one year 
to 86
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locations of laryngeal cancer. The risk of neck node meta-
stases is raised in supraglottic cancer, while the results
are comparable with data from literature [17-20]. Sko∏y-
szewski et al. stressed the necessity of larger field irra-
diation, including the larynx and upper neck nodes in all
patients with supraglottic cancer [3].
An assessment of five directions of extralaryngeal
infiltration (T4) has shown, that the least unfavorable
prognostic factor was the suspicion of cartilage infiltration
(56% of 3-year LC rate). The significantly lowest 3-year
LC rate (13.5%) was noted in cases of massive infiltration
including anatomical structures of the hypopharynx (pyri-
form recess) and the oropharynx (base of tongue). It se-
ems that the unexpectedly good results achieved in the
group of patients in whom cartilage infiltration was su-
spected may be connected with a possible misdiagnosis of
this symptom (at that time it was not possible to perform
a precise CT examinations in all patients). A low LC rate
in cases of pyriform recess and base of tongue infiltra-
tion is probably connected with the range and the depth
of these infiltrations (large tumour mass and frequent
ulcers suggest tumor radioresistance). Harwood et al. ha-
ve also reported a higher LC rate in the case of carotid
cartilage destruction, as compared to pyriform recess in-
filtration [21]. This part of our results suggests the ne-
cessity of performing routine accessory investigations (CT,
USG) in order to define the exact extent of laryngeal
cancer. The assessment of the extent of the advanced
primary tumor should not be based only on clinical exa-
mination and laryngoscopy (direct or indirect), as such
an attitude may sometimes lead to incorrect staging
(usu ally downstaging) of the primary tumor. Helical com-
puted tomography and nuclear magnetic resonance may
be most useful in such cases [10]. Pre-treatment exami-
nation with CT scan and MRI may allow for the selection
of patients with „favorable” tumors (egzophytic and su-
perficial infiltrations of larynx), who stand a fair chance
of cure and voice preservation after radiotherapy alone [7,
10].
The results of the performed analysis suggest that
the necessity to perform an emergency tracheosto-
my before radiotherapy is significantly and indepen-
dently connected with worse prognosis in patients with
advanced laryngeal cancer. Emergency tracheostomy
may favour local recurrence in this region, because of
neoplastic cell inoculation during this procedure [22-
-24]. Kowalski and Terhaard report a higher risk of re-
currence in the tracheostomy region and an increased
risk of death [25, 26]. Some authors recommend prima-
ry surgery followed by radiotherapy in such patients
[27]. It seems obvious that an emergency tracheostomy
may be connected with a number of other factors, such
as poor performance status, large mass of primary tu-
mor, deep infiltration and destruction of adjacent struc-
tures i.e. a probability of higher radioresistance of the tu-
mour.
Our material and literature data [7] draw attention
to the small number of patients with stage T4 glottic can-
cer. A probable reason for this is the fact that the glottic
space is relatively small and that low staged, early sympto-
matic (voice hoarseness) cancers are diagnosed most
often in this location. Extensive destructive cartilage infil-
trations which spread outside the larynx are often dia-
gnosed as supraglottic cancer (because of gross tumor
volume) or as so-called „transglottic cancer”. Therefore it
is difficult to establish either the glottic or supraglottic
origin of advanced primary tumours.
Our material also draws attention to the very small
number of patients who underwent „salvage surgery”
after radiotherapy alone. This problem was already
reported by Sko∏yszewski et al. [3], who had sugge-
sted that it may be caused by delayed diagnosis of re-
currence brought on by irregular follow-up. In such cases
radical surgery is impossible because of a large size of
the tumour; such patient are usually treated palliatively.
This problem extends beyond the subject of our report
and we have performed no such analysis. However there
is no doubt that this is a serious clinical problem, which
calls for more frequent follow-up, especially during first
12 months after treatment and for establishing more ef-
fective methods of early detection of failures after ra-
diotherapy. In the material analysed by Mendenhall et al.
„salvage surgery” was performed in a majority of pa-
tients with uncured primary tumor or with locoregional
recurrence [7]. It influenced significant improvement of
treatment results in patients with advanced laryngeal
cancer.
Treatment of advanced laryngeal cancer still remains
the subject of many clinical trials while two main direc-
tions of investigations remain an integral element of ra-
diotherapy research:
(a) investigations on unconventional methods of frac-
tionation (accelerated and hyperfractionated radio-
therapy) [28-33].
(b) investigations on chemo-radiotherapy [34].
The main purpose of many of these trials is voice
preservation – total laryngectomy or lymphangectomy is
reserved for the treatment of failures (salvage surgery).
Results of the few completed randomised trials have not
revealed any therapeutic benefit after conservative tre-
atment (chemo-radiotherapy vs surgery+radiothera-
py) assessed according to local control, regional control
and overall survival, although 1/2 – 2/3 of patients survi-
ve 3 to 5 years with voice preservation after such treat-
ment [34].
Conclusions
1. Conventional radiotherapy of advanced laryngeal can-
cer has limited effectiveness (about 45% of 3-year
DFS) as a method of radical treatment.
2. Poor prognostic factors in patients with advanced la-
ryngeal cancer (T3-4) undergoing radiotherapy alone
are: emergency tracheostomy and the presence of en-
larged neck nodes.
3. The location and extent of extralaryngeal infiltrations
influences the efficacy of radiotherapy in stage T4 la-
ryngeal cancer.
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4. A low percentage of patients, who underwent salvage
surgery after radiotherapy failures, indicates the ne-
cessity of developing more effective methods of early
detection and treatment of failures.
Anna Mucha-Ma∏ecka M.D.
Department of Radiotherapy
The Maria Sk∏odowska Curie Memorial Cancer Center
and Institute of Oncology
Wybrze˝e Armii Krajowej 15
44-101 Gliwice, Poland
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